Suvranu Ganguli, MD (he/him/his)

Chief, Interventional Radiology
Boston Medical Center/Boston University School of Medicine

Presentation(s):

• Y-90 Selective Internal Radiation Therapy for Ocular Melanoma Metastatic to the Liver: Dosimetry and Response Assessment

  Monday, March 6, 2023
  12:00 PM – 1:00 PM

  Disclosure(s): Avania: Advisory Committee or Review Panel Member (Ongoing); Boston Scientific: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing); Eisai: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing); Instylla: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing), Speaking and Teaching (Ongoing); Medtronic: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing); Sirtex: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing)

• Transarterial embolization/infusion IO

  Monday, March 6, 2023
  3:00 PM – 4:30 PM

  Disclosure(s): Avania: Advisory Committee or Review Panel Member (Ongoing); Boston Scientific: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing); Eisai: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing); Instylla: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing), Speaking and Teaching (Ongoing); Medtronic: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing); Sirtex: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing)

• Embolization 2

  Tuesday, March 7, 2023
  3:00 PM – 4:30 PM

  Disclosure information not submitted.

• Interventional Oncology: Complications

  Wednesday, March 8, 2023
  1:00 PM – 2:30 PM

  Disclosure(s): Avania: Advisory Committee or Review Panel Member (Ongoing); Boston Scientific: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing); Eisai: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing); Instylla: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing), Speaking and Teaching (Ongoing); Medtronic: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing); Sirtex: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing)

• Interventional Oncology Complication

  Wednesday, March 8, 2023
  1:00 PM – 1:13 PM

  Disclosure(s): Avania: Advisory Committee or Review Panel Member (Ongoing); Boston Scientific: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing); Eisai: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing); Instylla: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Ownership Interest (Ongoing), Speaking and Teaching (Ongoing); Medtronic: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing); Sirtex: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing)